These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15658879)

  • 1. Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
    Cheng H; Cao X; Xian M; Fang L; Cai TB; Ji JJ; Tunac JB; Sun D; Wang PG
    J Med Chem; 2005 Jan; 48(2):645-52. PubMed ID: 15658879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
    Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
    J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
    Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
    Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
    Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
    J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
    Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iminosugars from Baphia nitida Lodd.
    Kato A; Kato N; Miyauchi S; Minoshima Y; Adachi I; Ikeda K; Asano N; Watson AA; Nash RJ
    Phytochemistry; 2008 Mar; 69(5):1261-5. PubMed ID: 18191969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
    Crèvecoeur J; Merville MP; Piette J; Gloire G
    Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.
    Fang L; Battisti RF; Cheng H; Reigan P; Xin Y; Shen J; Ross D; Chan KK; Martin EW; Wang PG; Sun D
    J Med Chem; 2006 Oct; 49(21):6290-7. PubMed ID: 17034135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on quinones. Part 41: synthesis and cytotoxicity of isoquinoline-containing polycyclic quinones.
    Valderrama JA; González MF; Pessoa-Mahana D; Tapia RA; Fillion H; Pautet F; Rodriguez JA; Theoduloz C; Schmeda-Hirschmann G
    Bioorg Med Chem; 2006 Jul; 14(14):5003-11. PubMed ID: 16563773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition.
    Burkitt M; Magee C; O'Connor D; Campbell F; Cornford P; Greenhalf W
    Mol Carcinog; 2007 Jun; 46(6):466-75. PubMed ID: 17219417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
    Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
    J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a broad specificity beta-glucosidase from sheep liver.
    Chinchetru MA; Cabezas JA; Calvo P
    Int J Biochem; 1989; 21(5):469-76. PubMed ID: 2503402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.
    Maroney AC; Marugan JJ; Mezzasalma TM; Barnakov AN; Garrabrant TA; Weaner LE; Jones WJ; Barnakova LA; Koblish HK; Todd MJ; Masucci JA; Deckman IC; Galemmo RA; Johnson DL
    Biochemistry; 2006 May; 45(17):5678-85. PubMed ID: 16634649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy.
    Fang L; Sun D
    Drug Metab Dispos; 2008 Jun; 36(6):1153-65. PubMed ID: 18356268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel synthesis, cytotoxic evaluation, and structure-activity relationship studies of a series of alpha-alkylidene-gamma-lactones and lactams.
    Janecki T; Błaszczyk E; Studzian K; Janecka A; Krajewska U; Rózalski M
    J Med Chem; 2005 May; 48(10):3516-21. PubMed ID: 15887960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin: asymmetric glycolate aldol reactions and biological evaluation.
    Andrus MB; Meredith EL; Hicken EJ; Simmons BL; Glancey RR; Ma W
    J Org Chem; 2003 Oct; 68(21):8162-9. PubMed ID: 14535799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
    Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
    Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
    Chen C; Shi Y; Li S; Qi Q; Gu L; Song J; Wang PG
    Arch Pharm (Weinheim); 2006 Jul; 339(7):366-71. PubMed ID: 16783837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new kinetic model of recombinant beta-galactosidase from Kluyveromyces lactis for both hydrolysis and transgalactosylation reactions.
    Kim CS; Ji ES; Oh DK
    Biochem Biophys Res Commun; 2004 Apr; 316(3):738-43. PubMed ID: 15033461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.